Aviva’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,933
| Closed | -$538K | – | 904 |
|
|
2025
Q1 | $538K | Buy |
19,933
+4,156
| +26% | +$112K | ﹤0.01% | 787 |
|
|
2024
Q4 | $566K | Sell |
15,777
-1,040
| -6% | -$37.3K | ﹤0.01% | 766 |
|
|
2024
Q3 | $638K | Buy |
16,817
+3,668
| +28% | +$139K | ﹤0.01% | 767 |
|
|
2024
Q2 | $595K | Buy |
13,149
+134
| +1% | +$6.06K | ﹤0.01% | 794 |
|
|
2024
Q1 | $631K | Buy |
13,015
+331
| +3% | +$16.1K | ﹤0.01% | 817 |
|
|
2023
Q4 | $680K | Buy |
12,684
+2,819
| +29% | +$151K | ﹤0.01% | 750 |
|
|
2023
Q3 | $578K | Sell |
9,865
-12,842
| -57% | -$753K | ﹤0.01% | 825 |
|
|
2023
Q2 | $1.43M | Sell |
22,707
-581
| -2% | -$36.6K | 0.01% | 742 |
|
|
2023
Q1 | $1.46M | Buy |
23,288
+4,629
| +25% | +$291K | 0.01% | 758 |
|
|
2022
Q4 | $993K | Sell |
18,659
-6,670
| -26% | -$355K | ﹤0.01% | 834 |
|
|
2022
Q3 | $1.42M | Sell |
25,329
-2,791
| -10% | -$156K | 0.01% | 854 |
|
|
2022
Q2 | $2.04M | Buy |
28,120
+9,662
| +52% | +$699K | 0.01% | 799 |
|
|
2022
Q1 | $1.47M | Sell |
18,458
-6,704
| -27% | -$532K | 0.01% | 923 |
|
|
2021
Q4 | $2.55M | Buy |
25,162
+8,092
| +47% | +$819K | 0.01% | 786 |
|
|
2021
Q3 | $1.57M | Buy |
+17,070
| New | +$1.57M | 0.01% | 870 |
|
|
2021
Q2 | – | Sell |
-12,677
| Closed | -$1.24M | – | 977 |
|
|
2021
Q1 | $1.24M | Buy |
+12,677
| New | +$1.24M | 0.01% | 786 |
|